Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
Abstract
To determine the effectiveness of erenumab in treating headaches in idiopathic intracranial hypertension (IIH) in whom papilledema had resolved.Disability in IIH is predominantly driven by debilitating headaches with no evidence for the use of preventative therapies. Headache therapy in IIH is an urgent unmet need.A prospective, open-label study in the United Kingdom was conducted. Adult females with confirmed diagnosis of IIH now in ocular...
Paper Details
Title
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
Published Date
Dec 14, 2020
Journal
Volume
61
Issue
1
Pages
157 - 169
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History